Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Fisher

Showing results (121-130 of 251) with videos related to

Pageof 26
Sort By:
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Crystallization and preliminary X-ray analysis of binary and ternary complexes of Haloferax mediterranei glucose dehydrogenaseJulia Esclapez, K Linda Britton, Patrick J Baker, et al.
AIDS (London, England)|November 25, 2010
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirineLaura Waters, Martin Fisher, Alan Winston, et al.
Plos One|April 8, 2015
Home sampling for sexually transmitted infections and HIV in men who have sex with men: a prospective observational studyMartin Fisher, Sonali Wayal, Helen Smith, et al.
The Clinical Journal of Pain|October 21, 2014
Is HIV Painful? An Epidemiologic Study of the Prevalence and Risk Factors for Pain in HIV-infected PatientsEdwina Lawson, Caroline Sabin, Nicky Perry, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2009
A randomized comparative trial of continued zidovudine/lamivudine or replacement with tenofovir disoproxil fumarate/emtricitabine in efavirenz-treated HIV-1-infected individualsMartin Fisher, Graeme J Moyle, Mohsen Shahmanesh, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 2011
Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studiesStephen Taylor, Ashini Jayasuriya, Martin Fisher, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2012
Biomarkers to monitor safety in people on art and risk of mortalityLoveleen Bansi, Brian Gazzard, Frank Post, et al.
Endocrinology|February 26, 2014
Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivoEleni M Domouzoglou, Ffolliott Martin Fisher, Inna Astapova, et al.
Frontiers in Psychology|February 4, 2020
Demographics and Outcomes of Patients With Eating Disorders Treated in Residential CareMartin Fisher, Jennifer R Henretty, Shelbi A Cox, et al.
AIDS and Behavior|August 19, 2011
Behavioral surveillance study: sexual risk taking behaviour in UK HIV outpatient attendeesRichard Harding, Claudine Clucas, Fiona C Lampe, et al.
Pageof 26

Showing results (121-130 of 251) with videos related to

Sort By:
Pageof 26
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Crystallization and preliminary X-ray analysis of binary and ternary complexes of Haloferax mediterranei glucose dehydrogenaseJulia Esclapez, K Linda Britton, Patrick J Baker, et al.
AIDS (London, England)|November 25, 2010
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirineLaura Waters, Martin Fisher, Alan Winston, et al.
Plos One|April 8, 2015
Home sampling for sexually transmitted infections and HIV in men who have sex with men: a prospective observational studyMartin Fisher, Sonali Wayal, Helen Smith, et al.
The Clinical Journal of Pain|October 21, 2014
Is HIV Painful? An Epidemiologic Study of the Prevalence and Risk Factors for Pain in HIV-infected PatientsEdwina Lawson, Caroline Sabin, Nicky Perry, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2009
A randomized comparative trial of continued zidovudine/lamivudine or replacement with tenofovir disoproxil fumarate/emtricitabine in efavirenz-treated HIV-1-infected individualsMartin Fisher, Graeme J Moyle, Mohsen Shahmanesh, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 2011
Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studiesStephen Taylor, Ashini Jayasuriya, Martin Fisher, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2012
Biomarkers to monitor safety in people on art and risk of mortalityLoveleen Bansi, Brian Gazzard, Frank Post, et al.
Endocrinology|February 26, 2014
Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivoEleni M Domouzoglou, Ffolliott Martin Fisher, Inna Astapova, et al.
Frontiers in Psychology|February 4, 2020
Demographics and Outcomes of Patients With Eating Disorders Treated in Residential CareMartin Fisher, Jennifer R Henretty, Shelbi A Cox, et al.
AIDS and Behavior|August 19, 2011
Behavioral surveillance study: sexual risk taking behaviour in UK HIV outpatient attendeesRichard Harding, Claudine Clucas, Fiona C Lampe, et al.
Pageof 26